- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cellebrite DI (CLBT)
Cellebrite DI stock price live, this page displays NASDAQ CLBT stock exchange data. View the CLBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cellebrite DI real time stock price chart below.
What Is the Cellebrite DI Stock Price Today?
The Cellebrite DI stock price today is 15.830.
What Is the Stock Symbol for Cellebrite DI?
The stock symbol for Cellebrite DI is ""CLBT.""
What Stock Exchange Does Cellebrite DI Trade On?
Cellebrite DI is listed and trades on the NASDAQ stock exchange.
Is Cellebrite DI a Good Stock to Buy?
Determining whether Cellebrite DI—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLBT quote. (ISIN: IL0011794802)
What Is the Cellebrite DI Stock Price Today?
The Cellebrite DI stock price today is 15.830.
What Is the Stock Symbol for Cellebrite DI?
The stock symbol for Cellebrite DI is ""CLBT.""
What Stock Exchange Does Cellebrite DI Trade On?
Cellebrite DI is listed and trades on the NASDAQ stock exchange.
Is Cellebrite DI a Good Stock to Buy?
Determining whether Cellebrite DI—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLBT quote. (ISIN: IL0011794802)
NASDAQ
Currency in USD
Fair Value
An estimate of a Cellebrite's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.810
16.220
52 wk Range
13.100
26.300
CLBT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CLBT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cellebrite's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.81016.220
52 wk Range
13.10026.300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLBT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cellebrite's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
22.571
Upside
+42.59%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Cellebrite DI Company Profile
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company’s digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.
Cellebrite DI Earnings Call Summary for Q2/2025
- Cellebrite's Q2 2025 EPS of $0.08 beat forecasts by 3.76%, with revenue up 18% YoY to $113.3M; stock surged 11.51% in pre-market trading
- Company maintains 84.38% gross profit margins and holds more cash than debt; annual recurring revenue grew 21% to $419M
- Cellebrite announced $150M acquisition of Keryllium, focusing on AI integration to enhance product offerings and market position
- Full-year revenue guidance set at $465-$475M with ARR growth expected between 16-20%; optimism for improved federal spending in 2026
- CEO expressed confidence in growth trajectory; CRO emphasized strategic AI use, stating they won't simply add an LLM to claim AI capabilities
Last Updated: 21/08/2025, 15:42
Read Full TranscriptCompare CLBT to Peers and Sector
Metrics to compare | CLBT | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipCLBTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.6x | −26.2x | 11.7x | |
PEG Ratio | 1.09 | −2.33 | 0.01 | |
Price/Book | 9.5x | 3.3x | 2.4x | |
Price / LTM Sales | 8.9x | 2.8x | 2.2x | |
Upside (Analyst Target) | 38.5% | 52.7% | 17.9% | |
Fair Value Upside | Unlock | 7.6% | 5.5% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.571
(+42.59% Upside)
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
0.08 / 0.0771
Revenue / Forecast
113.28M / 115.32M
People Also Watch
FAQ
What Stock Exchange Does Cellebrite Trade On?
Cellebrite is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Cellebrite?
The stock symbol for Cellebrite is "CLBT."
What Is the Cellebrite Market Cap?
As of today, Cellebrite market cap is 3.88B.
What Is Cellebrite's Earnings Per Share (TTM)?
The Cellebrite EPS (TTM) is -0.66.
When Is the Next Cellebrite Earnings Date?
Cellebrite will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is CLBT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cellebrite Stock Split?
Cellebrite has split 0 times.
How Many Employees Does Cellebrite Have?
Cellebrite has 1167 employees.
What is the current trading status of Cellebrite (CLBT)?
As of 26 Aug 2025, Cellebrite (CLBT) is trading at a price of 15.83, with a previous close of 16.11. The stock has fluctuated within a day range of 15.81 to 16.22, while its 52-week range spans from 13.10 to 26.30.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.